Design and synthesis of α‐conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists
- 1 October 2013
- journal article
- research article
- Published by Wiley in Peptide Science
- Vol. 102 (1) , 78-87
Abstract
The α4β2 nicotinic acetylcholine receptor (nAChR) is an important target for currently approved smoking cessation therapeutics. However, the development of highly selective α4β2 nAChR antagonists remains a significant challenge. α‐Conotoxin GID is an antagonist of α4β2 nAChRs, though it is significantly more potent toward the α3β2 and α7 subtypes. With the goal of obtaining further insights into α‐conotoxin GID/nAChR interactions that could lead to the design of GID analogues with improved affinity for α4β2 nAChRs, we built a homology model of the GID/α4β2 complex using an X‐ray co‐crystal structure of an α‐conotoxin/acetylcholine binding protein (AChBP) complex. Several additional interactions that could potentially enhance the affinity of GID for α4β2 nAChRs were observed in our model, which led to the design and synthesis of 22 GID analogues. Seven analogues displayed inhibitory activity toward α4β2 nAChRs that was comparable to GID. Significantly, both GID[A10S] and GID[V13I] demonstrated moderately improved selectivity toward α4β2 over α3β2 when compared with GID, while GID[V18N] exhibited no measurable inhibitory activity for the α3β2 subtype, yet retained inhibitory activity for α4β2. In this regard, GID[V18N] is the most α4β2 nAChR selective α‐conotoxin analogue identified to date. © 2013 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 78–87, 2014.Keywords
This publication has 49 references indexed in Scilit:
- Crystal Structure of Lymnaea stagnalis AChBP Complexed with the Potent nAChR Antagonist DHβE Suggests a Unique Mode of AntagonismPLOS ONE, 2012
- Synthetic α-Conotoxin Mutants as Probes for Studying Nicotinic Acetylcholine Receptors and in the Development of Novel Drug LeadsToxins, 2010
- A Synthetic Combinatorial Strategy for Developing α-Conotoxin Analogs as Potent α7 Nicotinic Acetylcholine Receptor AntagonistsJournal of Biological Chemistry, 2010
- Insight in nAChR subtype selectivity from AChBP crystal structuresBiochemical Pharmacology, 2009
- Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptorsActa Pharmacologica Sinica, 2009
- Rational Design of α-Conotoxin Analogues Targeting α7 Nicotinic Acetylcholine ReceptorsJournal of Biological Chemistry, 2009
- Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapseNeuropsychopharmacology, 2008
- AChBP‐targeted α‐conotoxin correlates distinct binding orientations with nAChR subtype selectivityThe EMBO Journal, 2007
- Long-term effects of chronic nicotine exposure on brain nicotinic receptorsProceedings of the National Academy of Sciences, 2007
- Null mutant analysis of responses to nicotine: Deletion of β2 nicotinic acetylcholine receptor subunit but not α7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermiaNicotine & Tobacco Research, 2004